Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 241

1.

The combined effect of CYP2D6 and DRD2 Taq1A polymorphisms on the antipsychotics daily doses and hospital stay duration in schizophrenia inpatients (observational naturalistic study).

Kurylev AA, Brodyansky VM, Andreev BV, Kibitov AO, Limankin OV, Mosolov SN.

Psychiatr Danub. 2018 Jun;30(2):157-163. doi: 10.24869/psyd.2018.157.

2.

Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 polymorphisms using HRMA in Psychiatry patients with schizophrenia and bipolar disease for personalized medicine.

Yenilmez ED, Tamam L, Karaytug O, Tuli A.

Comb Chem High Throughput Screen. 2018 Jun 19. doi: 10.2174/1386207321666180619164726. [Epub ahead of print]

PMID:
29921201
3.

Clozapine toxicity in a CYP2D6 poor metaboliser: Additive effects of haloperidol and valproate on clozapine metabolism.

Reznik R, Chen RYY, Stanford P.

Australas Psychiatry. 2018 May 1:1039856218771509. doi: 10.1177/1039856218771509. [Epub ahead of print]

PMID:
29737183
4.

Pharmacoresistant Severe Mental Health Disorders in Children and Adolescents: Functional Abnormalities of Cytochrome P450 2D6.

Thümmler S, Dor E, David R, Leali G, Battista M, David A, Askenazy F, Verstuyft C.

Front Psychiatry. 2018 Jan 24;9:2. doi: 10.3389/fpsyt.2018.00002. eCollection 2018.

5.

ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting.

Papazisis G, Goulas A, Sarrigiannidis A, Bargiota S, Antoniadis D, Raikos N, Basgiouraki E, Bozikas VP, Garyfallos G.

Hum Psychopharmacol. 2018 Jan;33(1). doi: 10.1002/hup.2644. Epub 2017 Dec 18.

PMID:
29250824
6.

Pharmacokinetics and Safety of Brexpiprazole Following Multiple-Dose Administration to Japanese Patients With Schizophrenia.

Ishigooka J, Iwashita S, Higashi K, Liew EL, Tadori Y.

J Clin Pharmacol. 2018 Jan;58(1):74-80. doi: 10.1002/jcph.979. Epub 2017 Jul 27.

7.

A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting risperidone.

Schoretsanitis G, Spina E, Hiemke C, de Leon J.

Expert Rev Clin Pharmacol. 2017 Sep;10(9):965-981. doi: 10.1080/17512433.2017.1345623. Epub 2017 Jul 12. Review.

PMID:
28699847
8.

Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients.

Shi Y, Li M, Song C, Xu Q, Huo R, Shen L, Xing Q, Cui D, Li W, Zhao J, He L, Qin S.

Transl Psychiatry. 2017 Jul 11;7(7):e1170. doi: 10.1038/tp.2017.143.

9.

Identification of genetic correlates of response to Risperidone: Findings of a multicentric schizophrenia study from India.

Kaur G, Gupta D, Chavan BS, Sinhmar V, Prasad R, Tripathi A, Garg PD, Gupta R, Khurana H, Gautam S, Margoob MA, Aneja J.

Asian J Psychiatr. 2017 Oct;29:174-182. doi: 10.1016/j.ajp.2017.07.026. Epub 2017 Jul 6.

PMID:
28692863
10.

Risperidone Therapy and CYP2D6 Genotype.

Dean L.

In: Pratt V, McLeod H, Rubinstein W, Dean L, Malheiro A, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2017 Apr 10.

11.

Thioridazine Therapy and CYP2D6 Genotypes.

Dean L.

In: Pratt V, McLeod H, Rubinstein W, Dean L, Malheiro A, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2017 Feb 9.

12.

Aripiprazole Therapy and CYP2D6 Genotype.

Dean L.

In: Pratt V, McLeod H, Rubinstein W, Dean L, Malheiro A, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2016 Sep 22.

13.

Clozapine Therapy and CYP2D6, CYP1A2, and CYP3A4 Genotypes.

Dean L.

In: Pratt V, McLeod H, Rubinstein W, Dean L, Malheiro A, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2016 Jun 8.

14.

Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test.

Health Quality Ontario .

Ont Health Technol Assess Ser. 2017 Apr 11;17(4):1-39. eCollection 2017. Review.

15.

Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients.

Mas S, Gassó P, Torra M, Bioque M, Lobo A, González-Pinto A, Olmeda MS, Corripio I, Vieta E, Castro-Fornieles J, Rodriguez-Jimenez R, Bobes J, Usall J, Llerena A, Saiz-Ruiz J, Bernardo M, Lafuente A, PEPs Group.

Eur Neuropsychopharmacol. 2017 Jul;27(7):647-656. doi: 10.1016/j.euroneuro.2017.03.012. Epub 2017 Apr 5.

PMID:
28389049
16.

Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.

Tóth K, Csukly G, Sirok D, Belic A, Kiss Á, Háfra E, Déri M, Menus Á, Bitter I, Monostory K.

Int J Neuropsychopharmacol. 2017 Jul 1;20(7):529-537. doi: 10.1093/ijnp/pyx019.

17.

Exposure-response analysis after subcutaneous administration of RBP-7000, a once-a-month long-acting Atrigel formulation of risperidone.

Ivaturi V, Gopalakrishnan M, Gobburu JVS, Zhang W, Liu Y, Heidbreder C, Laffont CM.

Br J Clin Pharmacol. 2017 Jul;83(7):1476-1498. doi: 10.1111/bcp.13246. Epub 2017 Mar 31.

18.

CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia.

Zeng L, Kang C, Yuan J, Zhang Y, Wei Y, Xu L, Zhou F, Yang J.

Schizophr Res. 2017 Oct;188:50-51. doi: 10.1016/j.schres.2017.01.030. Epub 2017 Jan 26. No abstract available.

PMID:
28131599
19.

Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms.

Akamine Y, Sugawara-Kikuchi Y, Uno T, Shimizu T, Miura M.

Ann Clin Biochem. 2017 Nov;54(6):677-685. doi: 10.1177/0004563216686377. Epub 2017 Feb 8.

PMID:
27932669
20.

Influences of CYP2D6*10 polymorphisms on the pharmacokinetics of iloperidone and its metabolites in Chinese patients with schizophrenia: a population pharmacokinetic analysis.

Pei Q, Huang L, Huang J, Gu JK, Kuang Y, Zuo XC, Ding JJ, Tan HY, Guo CX, Liu SK, Yang GP.

Acta Pharmacol Sin. 2016 Nov;37(11):1499-1508. doi: 10.1038/aps.2016.96. Epub 2016 Sep 26.

Supplemental Content

Loading ...
Support Center